Clinical Trial Testing if Common Anti-Inflammatory Drug Reduces Hospitalization, Death Caused by Conornavirus

UCSF is recruiting newly diagnosed COVID-19 patients for a large global clinical trial testing whether the common anti-inflammatory drug colchicine can reduce hospitalization and death caused by the illness.